ADCT

Adc Therapeutics
$1.14
−$0.01 (−0.87%)Jul 27, 2026
0.2PoorMoatMint rating

MoatMint rates Adc Therapeutics (ADCT) 0.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.3 out of 10.

Key metrics

The numbers that frame ADCT today
Market cap
$145.00M
P/E (TTM)
-1.1
EV / FCF
-0.3
Gross margin
90.7%
EV / Sales
0.4
ROIC
-77.6%
Div yield
0%
52wk Low
$0.78
52wk High
$4.98

ADCT stock rating

How ADCT scores on quality, value, growth, momentum and financial health
0.2out of 10
Low overallNeutral business, expensive priceTop 98% of ~5,000 US stocks
QualityFair2.3/10
GrowthPoor1.8/10
MomentumPoor0.4/10
ValuePoor0.8/10
Financial HealthPoor0.3/10

Growth

Revenue and earnings trend for ADCT
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ADCT
Is Adc Therapeutics a good buy?
No. Adc Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Adc Therapeutics is selling at a very high price.
What is the market capitalization of ADCT?
Adc Therapeutics's market capitalization is $145.00M.
What is the P/E ratio for ADCT stock?
Adc Therapeutics's current P/E ratio is -1.1.
What is the 52-week high for ADCT stock?
The 52-week high for Adc Therapeutics is $4.98. The current close of $1.14 is 77.1% below that high.
What is the 52-week low for ADCT stock?
The 52-week low for Adc Therapeutics is $0.78. The current close of $1.14 is 46.2% above that low.
Does ADCT stock pay dividends?
Adc Therapeutics does not currently show a dividend per share in the company data.